Haruhiko Sugino

Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice

Y. Mitsumoto, Y. Marunaka, T. Futamura, 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Aripiprazole attenuates established behavioral sensitization induced by methamphetamine

R. Mcquade, A. Forbes, T. Kikuchi, 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Global Trends in Alzheimer Disease Clinical Development: Increasing the Probability of Success.

D. Kostic, Naoki Amada, Haruhiko Sugino, 2015, Clinical therapeutics.

Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator

Tine Bryan Stensbøl, C. Bundgaard, R. Mcquade, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Brexpiprazole II: Antipsychotic-Like and Procognitive Effects of a Novel Serotonin-Dopamine Activity Modulator

C. Bundgaard, R. Mcquade, J. Arnt, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Clozapine prevents a decrease in neurogenesis in mice repeatedly treated with phencyclidine.

H. Mizoguchi, T. Nagai, Kiyofumi Yamada, 2007, Journal of pharmacological sciences.

Brexpiprazole has a low risk of dopamine D2 receptor sensitization and inhibits rebound phenomena related to D2 and serotonin 5‐HT2A receptors in rats

T. Kikuchi, T. Futamura, Naoki Amada, 2019, Neuropsychopharmacology reports.

Global Trends in Alzheimer Disease Clinical Development: Increasing the Probability of Success.

D. Kostic, Naoki Amada, Haruhiko Sugino, 2015, Clinical therapeutics.

Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator

C. Bundgaard, R. Mcquade, H. Yamashita, 2014, The Journal of Pharmacology and Experimental Therapeutics.